Please login to the form below

Not currently logged in

FDA priority review for Roche’s Esbriet in unclassifiable interstitial lung disease

Agency is due to make a decision for the approval by May 2021

Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%

Eli Lilly new HQBamlanivimab-treated care home residents and staff had a significant reduction in COVID-19 risk

Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis

NICE (National for Health and Clinical Excellence)JAK inhibitor approved for use in moderate-to-severe RA

Janet Woodcock named acting commissioner of the FDA

Janet WoodcockPresident Biden is set to formally nominate a commissioner soon

Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find

COVID clinical trialResearchers used NHS Test and Trace data to identify benefit of lateral flow kits

Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant

Coronavirus vaccineBioNTech is planning to publish analysis on vaccine's efficacy against South African variant

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

Merck KGaABispecific antibody fails in non-small cell lung cancer trial

BMS aims for US approval of Opdivo combo in stomach cancer

BMS buildingUS regulator has set a goal date for a decision on 25 May

Shairose EbrahimQ&A: Shairose Ebrahim

PME interviews integrated medhealth communication (imc) group's President and CEO

Latest appointments

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...